Mayinglong Pharmaceutical Group Co Ltd Cash Flow Quality Index
Mayinglong Pharmaceutical Group Co Ltd cash flow quality index. Mayinglong Pharmaceutical Group Co Ltd (600993) has a Cash Flow Quality Index of 0.88x as of September 2025. Operating cash flow of CN¥139.20 Million is below net income of CN¥157.79 Million, suggesting accrual-heavy earnings not yet converted to cash. See 600993 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Mayinglong Pharmaceutical Group Co Ltd (2003–2025)
Cash flow quality index of Mayinglong Pharmaceutical Group Co Ltd from 2003 to 2025. Historical Cash Flow Quality Index for Mayinglong Pharmaceutical Group Co Ltd across 23 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Mayinglong Pharmaceutical Group Co Ltd (600993) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Mayinglong Pharmaceutical Group Co Ltd Cash Flow Quality Index by Year (2003–2025)
Mayinglong Pharmaceutical Group Co Ltd cash flow quality index by year from 2003 to 2025. Year-by-year earnings quality comparison for Mayinglong Pharmaceutical Group Co Ltd. For the full cash flow conversion analysis, see 600993 operating cash flow.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.03x | CN¥600.44 Million | CN¥581.49 Million | ▲ +13.8% |
| 2024 | 0.91x | CN¥497.61 Million | CN¥548.30 Million | ▼ -33.4% |
| 2023 | 1.36x | CN¥604.07 Million | CN¥443.25 Million | ▲ +91.5% |
| 2022 | 0.71x | CN¥341.85 Million | CN¥480.31 Million | ▼ -43.5% |
| 2021 | 1.26x | CN¥597.17 Million | CN¥474.05 Million | ▲ +91.7% |
| 2020 | 0.66x | CN¥282.99 Million | CN¥430.64 Million | ▼ -52.8% |
| 2019 | 1.39x | CN¥491.58 Million | CN¥353.40 Million | ▼ -25.7% |
| 2018 | 1.87x | CN¥308.24 Million | CN¥164.56 Million | ▲ +62.4% |
| 2017 | 1.15x | CN¥356.17 Million | CN¥308.85 Million | ▲ +12.1% |
| 2016 | 1.03x | CN¥239.60 Million | CN¥233.00 Million | ▲ +18.6% |
| 2015 | 0.87x | CN¥182.85 Million | CN¥210.94 Million | ▲ +49.2% |
| 2014 | 0.58x | CN¥111.67 Million | CN¥192.27 Million | ▼ -20.6% |
| 2013 | 0.73x | CN¥129.94 Million | CN¥177.68 Million | ▼ -27.6% |
| 2012 | 1.01x | CN¥169.25 Million | CN¥167.49 Million | ▲ +81.1% |
| 2011 | 0.56x | CN¥75.37 Million | CN¥135.03 Million | ▲ +685.3% |
| 2010 | -0.10x | CN¥-11.42 Million | CN¥119.76 Million | ▼ -108.3% |
| 2009 | 1.14x | CN¥216.11 Million | CN¥189.19 Million | ▼ -19.8% |
| 2008 | 1.42x | CN¥102.59 Million | CN¥72.00 Million | ▲ +3217.8% |
| 2007 | 0.04x | CN¥6.49 Million | CN¥151.00 Million | ▼ -95.7% |
| 2006 | 1.00x | CN¥75.27 Million | CN¥75.15 Million | ▲ +5.5% |
| 2005 | 0.95x | CN¥58.43 Million | CN¥61.57 Million | ▼ -10.1% |
| 2004 | 1.06x | CN¥54.19 Million | CN¥51.35 Million | ▼ -38.1% |
| 2003 | 1.70x | CN¥67.52 Million | CN¥39.61 Million | — |